|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2008-10-17
|
|
pubmed:abstractText |
There is an interest in the discovery of biopharmaceuticals, which are well tolerated and which potentiate the action of anthracyclines and taxanes in breast cancer therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6515-24
|
|
pubmed:meshHeading |
pubmed-meshheading:18927291-Adenocarcinoma,
pubmed-meshheading:18927291-Animals,
pubmed-meshheading:18927291-Antibodies, Monoclonal,
pubmed-meshheading:18927291-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18927291-Breast Neoplasms,
pubmed-meshheading:18927291-CHO Cells,
pubmed-meshheading:18927291-Cricetinae,
pubmed-meshheading:18927291-Cricetulus,
pubmed-meshheading:18927291-Doxorubicin,
pubmed-meshheading:18927291-Drug Synergism,
pubmed-meshheading:18927291-Female,
pubmed-meshheading:18927291-Flow Cytometry,
pubmed-meshheading:18927291-Fluorescent Antibody Technique,
pubmed-meshheading:18927291-Humans,
pubmed-meshheading:18927291-Immunoenzyme Techniques,
pubmed-meshheading:18927291-Immunoglobulin Fragments,
pubmed-meshheading:18927291-Interleukin-2,
pubmed-meshheading:18927291-Macaca fascicularis,
pubmed-meshheading:18927291-Mice,
pubmed-meshheading:18927291-Mice, Inbred BALB C,
pubmed-meshheading:18927291-Mice, Nude,
pubmed-meshheading:18927291-Paclitaxel,
pubmed-meshheading:18927291-Recombinant Fusion Proteins,
pubmed-meshheading:18927291-Stromal Cells,
pubmed-meshheading:18927291-Tenascin,
pubmed-meshheading:18927291-Tissue Distribution,
pubmed-meshheading:18927291-Tumor Cells, Cultured
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Antibody-mediated delivery of interleukin-2 to the stroma of breast cancer strongly enhances the potency of chemotherapy.
|
|
pubmed:affiliation |
Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
